Omnicell Inc. (OMCL)
NASDAQ: OMCLTechnologyComputer ManufacturingUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 35.21 0.00%
OMCL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.60B
- P/E (TTM)
- 41.92
- Forward P/E
- 16.85
- EPS (TTM)
- $0.84
- Dividend yield
- None
- 52-week range
- 29.06 – 55.00
- Day range
- 34.91 – 35.92
- Volume / Avg
- 570.63K / 677.88K
- Beta
- —
- Shares outstanding
- 45.48M
- Next earnings
- Oct 29, 2026
52-week range
OMCL stock today
Omnicell (OMCL) closed at $35.21 on Oct 7, down 0.71% (-$0.25), versus the S&P 500's 0.22% decline. Shares are 36.0% below their 52-week high of $55.00, set on Jan 13, 2026 and 21.2% above the 52-week low of $29.06, in the middle of the past year's range. OMCL is down 22.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 16.4%.
At 41.9x trailing earnings, Omnicell trades above the peer-group median of 19.6x. Its forward P/E of 16.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Omnicell's next earnings report is expected on Oct 29, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Omnicell
Company profileOmnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
- Sector
- Technology
- Industry
- Computer Manufacturing
- CEO
- Mr. Randall A. Lipps
- Headquarters
- Fort Worth, TX
- Employees
- 3,485
- IPO year
- 2001
- Website
- omnicell.com
Analyst forecast
ForecastConsensus (8 analysts)
strong_buy
Avg. price target
$57.86+64.33%
- Strong buy 1
- Buy 6
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $0.24
Omnicell peers
Technology sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XNDUXanadu Quantum Technologies Limited Class B Subordinate Voting Shares | 4.49 | -11.26% | $1.37B | vs OMCL |
| OSSOne Stop Systems Inc. | 7.95 | -4.68% | $198.31M | vs OMCL |
| SCKTSocket Mobile Inc. | 0.6642 | -19.98% | $5.51M | vs OMCL |
| HPQHP Inc. | 32.24 | +1.61% | $29.07B | vs OMCL |
| SMCISuper Micro Computer Inc. | 44.94 | +3.41% | $29.52B | vs OMCL |
| IBMInternational Business Machines Corporation | 220.51 | -0.35% | $207.75B | vs OMCL |
| DELLDell Technologies Inc. Class C | 578.96 | +0.86% | $368.11B | vs OMCL |
| AAPLApple Inc. | 336.67 | +0.91% | $4.91T | vs OMCL |
Indexes, lists and sector
Appears in lists
Largest Technology stocks
Omnicell stock FAQ
What is Omnicell's stock price today?
OMCL last traded at $35.21 as of Oct 7, 4:00 PM EDT, down 0.71% on the day. Prices are delayed at least 15 minutes.
When is Omnicell's next earnings date?
Omnicell is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $0.24.
What is OMCL's P/E ratio?
OMCL trades at a trailing P/E ratio of 41.92 and a forward P/E of 16.85, compared with a median of 19.6 for its closest peers.
Who is Omnicell's CEO?
Mr. Randall A. Lipps is the chief executive officer of Omnicell Inc., which has about 3,485 employees.
What is the OMCL 52-week high?
The 52-week high for OMCL is $55.00 and the 52-week low is $29.06. The stock is currently 36.0% below its high.